Vanguard Group’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $269K | Hold |
|
|||||
|
2024
Q1 | $271K | Hold |
|
|||||
|
2023
Q4 | $231K | Buy |
|
|||||
|
2023
Q3 | $177K | Sell |
|
|||||
|
2023
Q2 | $224K | Sell |
|
|||||
|
2023
Q1 | $231K | Sell |
|
|||||
|
2022
Q4 | $220K | Sell |
|
|||||
|
2022
Q3 | $344K | Sell |
|
|||||
|
2022
Q2 | $450K | Sell |
|
|||||
|
2022
Q1 | $864K | Sell |
|
|||||
|
2021
Q4 | $2.91M | Buy |
|
|||||
|
2021
Q3 | $3.56M | Buy |
|
|||||
|
2021
Q2 | $6.01M | Buy |
|
|||||
|
2021
Q1 | $5.01M | Buy |
|